Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease.
about
Prediction of pre-eclampsia: a protocol for systematic reviews of test accuracySubsequent risk of metabolic syndrome in women with a history of preeclampsia: data from the Health Examinees Study.Search for an association between V249I and T280M CX3CR1 genetic polymorphisms, endothelial injury and preeclampsia: the ECLAXIR study10-Year cardiovascular event risks for women who experienced hypertensive disorders in late pregnancy: the HyRAS study.The Role of Statins in Prevention of Preeclampsia: A Promise for the Future?Thrombophilia mediates lowering cardiovascular risk factors in women with a history of preeclampsia.Exposure to AT1 receptor autoantibodies during pregnancy increases susceptibility of the maternal heart to postpartum ischemia-reperfusion injury in rats.Causes and mechanisms of intrauterine hypoxia and its impact on the fetal cardiovascular system: a review.Increased microvascular vasodilation and cardiovascular risk following a pre-eclamptic pregnancy.Gestational hypoxia and epigenetic programming of brain development disorders.Cardiovascular risk estimation in women with a history of hypertensive pregnancy disorders at term: a longitudinal follow-up studyPrevention of vascular dysfunction after preeclampsia: a potential long-term outcome measure and an emerging goal for treatment.eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype.A Study on Atherogenic Indices of Pregnancy Induced Hypertension Patients as Compared to Normal Pregnant Women.Postpartum Vascular Dysfunction in the Reduced Uteroplacental Perfusion Model of PreeclampsiaImpaired neurovascular reactivity in the microvasculature of pregnant women with preeclampsia.Preterm delivery of a first child and subsequent mothers' risk of ischaemic heart disease: a nested case-control studyHigh blood pressure during pregnancy is associated with future cardiovascular disease: an observational cohort study.Genetic polymorphisms of glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) and susceptibility to pre-eclampsia: a case-control study and a meta-analysis.Short- and long-term strategies for the management of hypertensive disorders of pregnancy.Markers of preeclampsia and the relationship to cardiovascular disease: review of the twenty-first century literature.Hypertensive disorders of pregnancy: preventative-, immediate- and long-term management.Maternal serum Chlamydia pneumoniae antibodies and CRP levels in women with preeclampsia and gestational hypertension.Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk.Maternal preeclampsia and risk for cardiovascular disease in offspring.Potential role of folate in pre-eclampsia.Hypertension in pregnancy.Women's perception of future risk following pregnancies complicated by preeclampsia.Risk of coronary artery disease in women with history of pregnancies complicated by preeclampsia and LBW.Gestational hypertensive disorders and retinal microvasculature: the Generation R Study.Long-term maternal cardiovascular function in a mouse model of sFlt-1-induced preeclampsia.Pre-eclampsia outcomes in different hemodynamic models.A Maternally Sequestered, Biopolymer‐Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia.
P2860
Q28200816-9FE1E16D-511F-4EFA-9BFF-4AD44DA1CDEFQ30907511-27A22A2B-988C-483C-93F7-FFE54554CBDAQ33479988-5EBBD95C-01CC-4F1B-B249-8B985ED634AEQ33591844-E2C01CCC-BA80-4227-B5BD-135A46478E92Q33639463-03221C83-7988-4441-970F-93EFC4928A75Q33699211-1FA5DC7B-2A4E-4B6A-B273-8F3556EF3A7BQ34072217-F64CBE58-4D47-4341-BC6B-96A1C4C04DB0Q34235812-21D8FF3B-469E-46A0-B7DD-791CA767EA7CQ34631972-32EE398D-8378-4A8F-84BD-96BFCB617055Q34674453-F47585F1-56F0-4149-88B9-05F24DC27C66Q34756489-9D9F398F-B93A-4374-8923-D03E9B38916BQ35607434-883D13EA-374F-4EB8-BEEB-F48DEBB88467Q35853296-CD387BBD-B959-48AC-980D-A75DFFCF67D3Q36067996-E3FEF35B-0609-4F6A-95AF-521C24A5B877Q36141421-E1E794FD-2485-4D0F-8876-0F6313C80B3FQ36381293-FD95380C-1F84-4F33-BD07-1816DF7B7033Q36854224-B630B032-AA79-4D4D-B2C4-A9C2057309CAQ37065032-99001AD2-AF5F-4CF5-B775-63C8BF50CC2EQ37413791-CA6C39CB-75B9-43D5-933A-16756E0A6F80Q37642835-5C0B74E6-8233-486A-92D3-4C035394830EQ37748773-3B1D04F8-45BE-4DCB-B451-D737834C5CEDQ37763163-DB7A16E1-47B5-4AB8-9D01-C5D9C1B27709Q37857465-3FC8AAD5-61D4-4EC9-9417-7539A67BC676Q37990465-B704A187-4FFF-472D-BD5B-8FD22E980569Q38237357-273F218D-0EF0-48A5-9349-12CB526573EDQ38584627-85BB6027-9FD7-4C48-B8FA-ACC7BF25B362Q39260574-07BAAF6E-60B5-4938-A19E-51337C6679D9Q39556730-5B05EF46-8893-4F5E-99F4-B9D80989F351Q39706974-29E1F0E7-0868-4AE8-8088-14CC5FC9AC32Q40084757-CC8F42FA-A823-4252-9118-5BD85A684E0CQ43241919-36947C5E-FD97-45A8-ABA7-447B5D6FDC38Q46336679-7D74D86D-0526-489B-903B-C8AFD86198A2Q49212311-C485E9B1-E3EC-4E28-99C5-15B3187CF589
P2860
Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Microvascular dysfunction: a l ...... ternal coronary heart disease.
@ast
Microvascular dysfunction: a l ...... ternal coronary heart disease.
@en
type
label
Microvascular dysfunction: a l ...... ternal coronary heart disease.
@ast
Microvascular dysfunction: a l ...... ternal coronary heart disease.
@en
prefLabel
Microvascular dysfunction: a l ...... ternal coronary heart disease.
@ast
Microvascular dysfunction: a l ...... ternal coronary heart disease.
@en
P2093
P1476
Microvascular dysfunction: a l ...... ternal coronary heart disease.
@en
P2093
Frances Stewart
Ian A Greer
Jane E Ramsay
P304
P356
10.1111/J.1471-0528.2003.02069.X
P577
2003-11-01T00:00:00Z